Glucose

CHICAGO — The growing abundance of technology options for better diabetes management and the trend away from HbA1c as the only evaluation metric for the condition are important parallel phenomena, according to a speaker at the Cardiometabolic Health Congress.

HOUSTON — Standardized continuous glucose monitoring metrics and time-in-range targets can help patients and diabetes care and education specialists work together to achieve agreed-upon goals and personalize glucose management decisions, according to two speakers at the American Association of Diabetes Educators annual meeting.

Top-line results from the CAROLINA study released Thursday demonstrated that the DPP-IV inhibitor linagliptin was noninferior vs. glimepiride for time to first major adverse cardiovascular event in adults with type 2 diabetes at high CV risk, according to a press release from Boehringer Ingelheim and Eli Lilly.